64 52

Cited 1 times in

Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.

DC FieldValueLanguage
dc.contributor.author강석구-
dc.date.accessioned2018-11-16T16:45:38Z-
dc.date.available2018-11-16T16:45:38Z-
dc.date.issued2018-
dc.identifier.issn1226-3613-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/165295-
dc.description.abstractGlioblastoma is a highly malignant tumor that easily acquires resistance to treatment. The stem-cell-like character (stemness) has been thought to be closely associated with the treatment resistance of glioblastoma cells. In this study, we determined that farnesyl diphosphate synthase (FDPS), a key enzyme in isoprenoid biosynthesis, plays an important role in maintaining glioblastoma stemness. A comparison of the mRNA expression in patient-derived glioblastoma sphere cells, which maintain stemness, and their differentiated counterparts, which lose stemness, via RNA sequencing showed that most of the altered genes were networked in the cholesterol biosynthesis pathway. We screened Federal Drug Administration (FDA)-approved drugs targeting specific enzymes in the cholesterol biosynthesis pathway for their ability to inhibit glioblastoma sphere formation. Inhibitors of FDPS, such as alendronate and zoledronate, significantly reduced the formation of glioblastoma spheres, and alendronate was effective at a lower molar concentration than zoledronate. Knockdown of FDPS using short hairpin RNA also completely inhibited the formation of secondary spheres. FDPS mRNA in patients with glioblastoma was associated with malignancy in three independent microarray data sets. RNA sequencing showed that alendronate treatment reduced the embryonic stem cell signature and activated development- and necrosis-related pathways in glioblastoma spheres. These results suggest that FDPS is important for the maintenance of glioblastoma stemness and that alendronate, a drug widely used to treat osteoporosis, can be repositioned to treat glioblastoma.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherNature Publishing Group-
dc.relation.isPartOfExperimental and Molecular Medicine-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleFarnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Neurosurgery (신경외과학교실)-
dc.contributor.googleauthorHee Yeon Kim-
dc.contributor.googleauthorDong Keon Kim-
dc.contributor.googleauthorSeung-Hyun Bae-
dc.contributor.googleauthorHyeRan Gwak-
dc.contributor.googleauthorJi Hoon Jeon-
dc.contributor.googleauthorJong Kwang Kim-
dc.contributor.googleauthorByung Il Lee-
dc.contributor.googleauthorHye Jin You-
dc.contributor.googleauthorDong Hoon Shin-
dc.contributor.googleauthorYoung-Ho Kim-
dc.contributor.googleauthorSoo Youl Kim-
dc.contributor.googleauthorSung-Sik Han-
dc.contributor.googleauthorJin-Kyoung Shim-
dc.contributor.googleauthorJi-Hyun Lee-
dc.contributor.googleauthorSeok-Gu Kang-
dc.contributor.googleauthorHyonchol Jang-
dc.identifier.doi10.1038/s12276-018-0166-2-
dc.contributor.localIdA00036-
dc.contributor.localIdA00036-
dc.relation.journalcodeJ00860-
dc.identifier.eissn2092-6413-
dc.identifier.pmid30333528-
dc.contributor.alternativeNameKang, Seok Gu-
dc.contributor.affiliatedAuthor강석구-
dc.citation.volume50-
dc.citation.number10-
dc.citation.startPage137-
dc.identifier.bibliographicCitationExperimental and Molecular Medicine, Vol.50(10) : 137, 2018-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.